This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Incospharm Corporation. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Innovations of Seok Jeong Yoon
Introduction
Seok Jeong Yoon is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medicinal and cosmetic compositions, holding a total of four patents. His work focuses on innovative solutions for skin inflammation and hyperpigmentation disorders.
Latest Patents
One of his latest patents is titled "Autophagy activation-induced compound for improving skin inflammation for aging." This patent provides a novel autophagy activation-inducing compound or its salt, which is used in medicinal compositions for treating and preventing neurodegenerative diseases, type II diabetes, and skin conditions such as atopy or psoriasis dermatitis. Additionally, it includes a cosmetic composition aimed at alleviating aging and related skin issues. Another significant patent is "Compounds, cosmetic composition and pharmaceutical composition comprising the same." This invention discloses a novel compound that activates autophagy to induce melanosome degradation, effectively preventing and treating melanin hyperpigmentation disorders.
Career Highlights
Seok Jeong Yoon is associated with Incospharm Corporation, where he continues to innovate in the field of dermatological solutions. His work has garnered attention for its potential impact on both medical and cosmetic applications.
Collaborations
He collaborates with notable colleagues, including Myung Ho Kor and Heung Jae Kim, contributing to a dynamic research environment that fosters innovation.
Conclusion
Seok Jeong Yoon's contributions to the field of skin health through his innovative patents highlight his role as a leading inventor in the industry. His work not only addresses critical health issues but also enhances the quality of life for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile